Cell Therapy Market Size to Surpass US$ 60.67 Billion by 2030

Ottawa, May 12, 2022 (GLOBE NEWSWIRE) -- The global cell therapy market size was estimated at US$ 10.35 billion in 2021. The governments all over the world are constantly investing in the biopharmaceutical industry's development. This has a direct impact on the worldwide cell therapy market's growth. For the introduction of innovative cell treatments into the worldwide market, leading industry participants are partnering with government authorities.

Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1700

Furthermore, for the growth and development of the global cell therapy market, industry participants are focusing on existing and developing areas. The high cost of cell therapies, on the other hand, is a major impediment to the worldwide cell therapy market's expansion. Furthermore, the cell treatment market's expansion is hampered by a scarcity of experienced personnel. However, due to the vast range of applications for cell therapy, the worldwide cell therapy market is likely to rise rapidly in the near future.

Regional Snapshot

North America is the largest segment for cell therapy market in terms of region. The U.S. is dominating the cell therapy market in the North America region. For the development of the cell therapy industry, variables such as rising chronic disease occurrences and increasing investments are important. Furthermore, expanding uses of stem cell technology for the treatment of various ailments are propelling the cell therapy market in North America. In addition, the market for cell treatment in North America is rising due to increased research and development activities.

Asia-Pacific region is the fastest growing region in the cell therapy market. China holds the highest market share in the Asia-Pacific cell therapy market. The expansion of the cell therapy market in this region is aided by favorable government policies. In addition, as a result of enhanced healthcare facilities, reduced costs, and rise in awareness of cell therapy, growing nations are expected to rise.

Scope of the Report

Ask here for more customization study@ https://www.precedenceresearch.com/customization/1700

Report Highlights

• On the basis of user type, research use segment holds the largest market share in the global cell therapy market. Cell treatment is commonly employed in scientific studies. The segment’s expansion is being fueled by an increase in research and development projects. Furthermore, important industry participants are heavily spending in research programs. Not only are market participants participating in research projects, but government organizations are also partnering on cell-based research.
  
  
• On the basis of therapy type, autologous therapies segment holds the largest market share in the global cell therapy market. The increased usage of autologous therapies on a large scale is credited for the segment’s rise. Furthermore, when compared to allogenic therapies, autologous therapies are very cost effective. As a result, this element is propelling the segment forward.
  
  

Market Dynamics

Drivers

Growing approvals for cell-based therapies

The cell therapies are getting approved easily by government agencies. Since FDA approved products are readily available in developing regions, cell treatments are commonly used. For example, the FDA granted Novartis’ Kymriah regenerative medicine enhanced therapy designation in April 2020 for the treatment of refractory follicular lymphoma in adults. The FDA authorized brexucabtagene autoleucel, a CAR T-cell treatment for patients with mantle cell lymphoma in July 2020.

Restraints

High capital investments for cell therapy plants

People seeking the most up to date alternative remedies for the various ailments have become increasingly interested in stem cell therapy nowadays. Every day, new sorts of therapies are launched and individuals all over the globe are turning to them instead of standard drug regimens and hospital visits. Despite the high demand for stem cell therapies, they are still prohibitively costly to develop. Simple joint injections can set back about $1,000 while more complex procedures can cost up to $100,000 depending on the issue.

Opportunities

Growing government initiatives

The government is heavily investing in research and development activities. The Australian government published The Stem Cell Therapies Mission, journey of 10 years for stem cell research, in November 2019. The Medical Research Future Fund would receive $102 million to support stem cell research in order to develop novel medicines. Thus, the growing government initiatives are creating lucrative opportunities for the growth of global cell therapy market.

Challenges

Lack of skilled professionals

The lack of skilled professionals is a major challenge faced by global cell therapy market. As per the National Accrediting Agency for Clinical Laboratory Sciences, there is a global demand supply mismatch for competent personnel. According to a research study conducted by the Gatsby Foundation, the UK will require an additional 700,000 professionals to sustain the economy by 2030.

Related Reports

• Stem Cells Market Research Report 2020 - 2027
• Cell and Tissue Preservation Market Research Report 2022 – 2030
• Cell Lysis & Disruption Market Research Report 2021 - 2030
  
  

Recent Developments

• Novadip Biosciences’ regenerative bone medicine NVD-003 for the treatment of uncommon pediatric bone disorders gained approval from the FDA in March 2021.
• In Boston, Takeda Pharmaceutical opened a 24,000 square foot research and development cell therapy manufacturing plant in 2020. Due to the introduction of stem cell therapy as a new treatment solution for patients with autoimmune disorders such as advancements in combination with the increased cases of rheumatoid arthritis among female, would accelerate the deployment of cell therapy medications.

Market Segmentation

By Use Type

• Clinical use
  • By Therapeutic Area
    • Malignancies
    • Muscoskeletal Disorders
    • Autoimmune Disorders
    • Dermatology
    • Cardiovascular
    • Ocular
    • Wounds and injuries
    • Others
  • By Cell Type
    • Stem Cell Therapies
    • BM, Blood, & Umbilical cord-derived Stem Cells
    • Adipose-derived cells
    • Others
  • Non-stem Cell Therapies
• Research use
  
  

By Therapy Type

• Autologous Therapies
• Allogenic Therapies

By End User

• Hospitals & Clinics
• Academic & Research Institutes

By Geography 

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)
  
  

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1700

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R